The Commonwealth Fund25m
What Pharmacy Benefit Managers Do, and How They Contribute to Drug Spending
Policymakers at the federal and state level have considered a number of reforms, many of which have bipartisan support, to ...
CT legislators take aim at high cost of prescription drugs
The bill, which encompasses the recommendations of a task force, would regulate pharmacy benefit managers and increase price ...
Florida demands patient names, prescriptions from drug middlemen
The Office of Insurance Regulation is demanding the unusual trove of data from pharmacy benefit managers — health care ...
Trump's tariffs, trade war with China could worsen prescription drug shortages in US
Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.
Employers Get Big Drug Discounts Through Program For Hospitals That Serve Poor Patients
The government program, known as 340B, allows hospitals that care for many uninsured and low-income patients to purchase ...
Why Florida wants companies to turn over personal data about customers’ prescriptions
What is it that the PBM industry doesn’t want you to know?” asked the CEO of the Florida Pharmacy Association.
The Washington Post4d
Maryland moves to make medicine cheaper amid economic uncertainty
The Maryland General Assembly appears to be on its way to expanding the authority of its Prescription Drug Affordability Board, empowering the first such entity in the nation to find ways to bring ...
pharmaphorum1d
The rise of prescription drug abuse and drug diversion
As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased. Ben Hargreaves speaks to an expert in the area to learn how ...
Business Wire5d
LGM Pharma Invests $6M in U.S. Drug Manufacturing Capabilities for Liquids, Suspensions, Semi-Solids, and Suppositories
This investment comes as LGM Pharma experiences sustained growth in prescription drug projects, including 505(b)(2) and Abbreviated New Drug Application (ANDA) programs. The Rosenberg facility ...
Medicare Agency to End Some Demonstration Projects, Cancel $2 Generic Drug Initiative
The Centers for Medicare and Medicaid Services plans to terminate four demonstration projects by the end of 2025, closing out ...
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...